metricas
covid
Buscar en
Enfermedades Infecciosas y Microbiología Clínica
Toda la web
Inicio Enfermedades Infecciosas y Microbiología Clínica In vitro activity of six biocides against carbapenemase-producing Klebsiella pne...
Información de la revista
Vol. 40. Núm. 7.
Páginas 371-376 (agosto - septiembre 2022)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Visitas
1226
Vol. 40. Núm. 7.
Páginas 371-376 (agosto - septiembre 2022)
Original article
Acceso a texto completo
In vitro activity of six biocides against carbapenemase-producing Klebsiella pneumoniae and presence of genes encoding efflux pumps
Actividad in vitro de seis biocidas frente a Klebsiella pneumoniae productora de carbapenemasa y presencia de genes codificantes de bombas de expulsión
Visitas
1226
Ana Gual-de-Torrellaa,b, Mercedes Delgado-Valverdea,b, Patricia Pérez-Palaciosa,b, Jesús Oteo-Iglesiasb,c, Álvaro Pascuala,b,d,1, Felipe Fernández-Cuencaa,b,1,
Autor para correspondencia
felipefc@us.es

Corresponding author.
a UGC Enfermedades Infecciosas, Microbiología Clínica, Instituto de Biomedicina de Sevilla (IBIS), Hospital Universitario Virgen Macarena/CSIC/Universidad de Sevilla, Sevilla, Spain
b Spanish Network for the Research in Infectious Diseases (REIPI RD16/0016), Instituto de Salud Carlos III, Madrid, Spain
c Laboratorio de Referencia e Investigación en Resistencia a Antibióticos e Infecciones relacionadas con la Asistencia Sanitaria, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain
d Departamento de Microbiología, Universidad de Sevilla, Sevilla, Spain
Este artículo ha recibido
Información del artículo
Resumen
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Abstract
Introduction

Acquisition of reduced susceptibility to biocides may contribute to the dissemination of high-risk (HR) clones of carbapenemase-producing Klebsiella pneumoniae (CP-Kp). The aim of this study was (a) to determinate the activity of biocides against CP-Kp, and (b) to analyse the relationship between biocide activity and the presence of efflux pumps.

Methods

The minimal inhibitory concentrations (MICs) of 6 biocides (sodium hypochlorite, chlorhexidine digluconate, benzalkonium chloride, povidone-iodine, ethanol and triclosan) were determined in triplicate at 25°C and 37°C in Mueller-Hinton broth (MHB) and M9 minimum medium, against 17 CP-Kp isolates representing different clones (HR and no-HR), sequence-types (STs) and carbapenemases. Efflux pumps genes were detected by whole genome sequencing (MiSeq).

Results

Median MICs were slightly higher at 37°C than at 25°C (p0.05), except for benzalkonium chloride, triclosan and ethanol. MIC medians were much higher in MHB than in M9, except for triclosan. No significant differences were observed in the median MICs, regarding the type of clone, ST or carbapenemase; cepA, acrAB, kpnEF and oqxAB genes were detected in all isolates, whereas qacE and qacA were not detected; smvAR, and qacΔE genes were detected in 94% and 47% of isolates, respectively.

Conclusions

Triclosan, chlorhexidine digluconate, benzalkonium chloride and ethanol were the most active biocides. The activity of some biocides is affected by temperature and growth media, suggesting that standardised procedures for biocide susceptibility testing based on MIC determination are required. This activity, in terms of MICs, are not related to the type of clone, ST, carbapenemase or the presence of the efflux pump genes.

Keywords:
Klebsiella pneumoniae
Carbapenemase
High-risk clone
Biocides
Efflux pumps
Abbreviations:
CP
Kp
HR
EP
MHB
RSB
BEN
CHX
ETH
POV
SOD
TRI
WGS
ST
Resumen
Introducción

La adquisición de sensibilidad reducida a los biocidas puede contribuir a la diseminación de clones de alto riesgo (HR) de Klebsiella pneumoniae productor de carbapenemasa (Kp-PC). El objetivo de este trabajo fue: (a) determinar la actividad de varios biocidas frente a Kp-PC, y (b) analizar la relación de dicha actividad con la presencia de genes codificantes de bombas de expulsión.

Métodos

Las concentraciones mínimas inhibitorias (CMI) de 6 biocidas (hipoclorito de sodio, digluconato de clorhexidina, cloruro de benzalconio, povidona yodada, etanol y triclosán) se determinaron por triplicado a 25 y 37°C, tanto en caldo Mueller-Hinton (MHB) como en medio mínimo M9, frente a 17 aislados de Kp-PC representativos de diferentes clones (HR y no HR), secuenciotipos (ST) y carbapenemasas. Los genes de bombas de expulsión se detectaron mediante secuenciación masiva del genoma completo (MiSeq).

Resultados

Las medianas de las CMI fueron ligeramente superiores a 37°C que a 25°C, excepto para cloruro de benzalconio, etanol y triclosán. Las medianas de las CMI fueron considerablemente superiores en MHB que en M9, excepto para triclosán; cepA, acrAB, kpnEF y oqxAB se detectaron en todos los aislados, mientras que qacE y qacA no se detectaron; smvAR y qacΔE se detectaron en el 94% y en el 47% de los aislados, respectivamente.

Conclusiones

La actividad de algunos biocidas se afecta por la temperatura y el medio de crecimiento. Esta actividad, en términos de CMI, no se relaciona con el tipo de clon, ST, carbapenemasa, ni con la presencia de genes que codifican bombas de expulsión.

Palabras clave:
Klebsiella pneumoniae
Carbapenemasa
Clon de alto riesgo
Desinfectantes
Bombas de expulsión
Texto completo
Introduction

Although Klebsiella pneumoniae (Kp) is part of the human intestinal microbiota, it can behave as an opportunistic nosocomial pathogen able to cause severe infections.1

High-risk (HR) clones of Kp are characterised by their enhanced ability to cause nosocomial outbreaks and to develop or acquire resistance to multiple antimicrobials, including carbapenems.2 The horizontal transfer of plasmids coding for carbapenemase genes is one of the most important factors contributing to the success of these epidemic clones.2 The dissemination of these carbapenemase-producing (CP)-HR clones has a major impact on the management of infections, due to the associated high morbidity and mortality, limited therapeutic options, and the difficulty of outbreaks control.1 Loss or reduced expression of certain porins or overexpression of efflux pumps (e.g., acrAB-TolC), combined with other mechanisms have been shown to be involved in carbapenem resistance in Kp.1

Environmental contamination (e.g., wastewater drainage system) by carbapenem-resistant Enterobacterales has been described as an increasing occult reservoir for CP-Kp outbreaks, so that any factor that facilitates its persistence in the environment through tolerance development or acquisition of reduced susceptibility to biocides (RSB) could improve the success or epidemic behaviour of some CP-HR clones of Kp.3–5

The biocide concentrations used in hospitals are high enough to prevent bacterial growth. Nevertheless, inadequate biocide preparation or loss of effectiveness due to environmental conditions can result in the presence of residual or subinhibitory biocide concentrations that could favour (i) the persistence and selection of some CP-HR clones of Kp and/or (ii) the co-selection of some acquired antimicrobial resistance determinants, as has been observed in other nosocomial bacteria.6–8

The main mechanism involved in RSB are efflux pumps.5,8 Efflux pumps can use only a specific biocide as substrate (e.g., chlorhexidine digluconate for CepA and SmvA) or several compounds, including different biocides and antimicrobials as substrates (e.g., chlorhexidine digluconate and benzalkonium chloride for QacA, QacE and QacΔE, and also triclosan for KpnEF and OqxAB).9–12

In Kp this information is scarce, but some efflux pumps, such as QacA, QacΔE, have been related to the development of reduced susceptibility or tolerance to chlorhexidine digluconate and benzalkonium chloride, among others.9

The aim of this study was (i) to determine the in vitro activity of some biocides commonly used in hospitals against representative HR and non-HR clones of CP-Kp; (ii) to evaluate the effect of some environmental conditions (temperature and type of growth medium) on the in vitro activity of biocides, and (iii) to analyse the relationship between presence of efflux pumps and the activity of the biocides tested.

Materials and methodsBacterial isolates

Seventeen CP-Kp isolates representing different types of carbapenemases and clones (sequence types) circulating in Spanish hospitals during 2012–2015 were selected (Table 1). Eleven isolates were from a multicenter Spanish study performed at the Reference and Research for Resistance to Antibiotics Laboratory of Carlos III Health Institute, Madrid, and 6 isolates were from the Reference Laboratory for the Surveillance and Control of Nosocomial Infections and Prudent Use of Antimicrobials Program in Andalucía (PIRASOA Program; Hospital Universitario Virgen Macarena, Seville, Spain).13

Table 1.

Relevant characteristics of the 17 carbapenemase-producing K. pneumoniae isolates.

Isolate number  Sequence typea  Sourceb  High-risk clone  Genes coding forMIC (mg/L)c
        Carbapenemases  CTX-M type ESBLs  ETP  IMP  MEM 
ST101  CNM  Yes  blaKPC-2  blaCTX-M-15  >1  >8  >8 
ST258  PIRASOA  Yes  blaKPC-3  No  >1  >8  >8 
ST512  PIRASOA  Yes  blaKPC-3  No  >1  8  8 
ST11  CNM  Yes  blaVIM-1  blaCTX-M-15  >1 
ST15  CNM  Yes  blaVIM-1  No  >1  8  8 
ST147  CNM  Yes  blaVIM-1  blaCTX-M-9  >1  4  8 
ST11  CNM  Yes  blaOXA-245  blaCTX-M-15  >1  ≤1  ≤1 
ST11  PIRASOA  Yes  blaOXA-48  blaCTX-M-15  ≤1  ≤1  ≤1 
ST15  PIRASOA  Yes  blaOXA-48  blaCTX-M-15  >1  4  ≤1 
10  ST37  PIRASOA  Yes  blaOXA-48  No  >1  ≤1  4 
11  ST405  CNM  Yes  blaOXA-48  blaCTX-M-15  >1  ≤1  ≤1 
12  ST340  CNM  No  blaVIM-1  No  >1 
13  ST437  CNM  No  blaOXA-245  No  >1  ≤1  ≤1 
14  ST13  CNM  No  blaOXA-48  No  >1  ≤1 
15  ST16  CNM  No  blaOXA-48  blaCTX-M-15  >1  ≤1  ≤1 
16  ST846  CNM  No  blaOXA-48  blaCTX-M-15  >1  4  >8 
17  ST899  PIRASOA  No  blaOXA-48  No  >1 
a

ST: sequence-type.

b

CNM: National Center for Microbiology. PIRASOA: Reference Laboratory for the Surveillance and Control of Nosocomial Infections and Prudent Use of Antimicrobials Program in Andalucía.

c

ETP: ertapenem, IMP: imipenem, MEM: meropenem. MICs associated to non-susceptibility appears in bold.

Susceptibility testing of biocides

Six biocides were selected for susceptibility testing; povidone-iodine (POV; Betadine®, MEDA Pharma SAU, Spain), sodium hypochlorite (SOD; Lejía Chari, Rubio Díaz Hnos, S.L., Spain), chlorhexidine digluconate (CHX; Sigma–Aldrich, San Luis, USA), benzalkonium chloride (BEN; Sigma–Aldrich, San Luis, USA), ethanol (ETH; Vaza Laboratorios, Spain), and triclosan (TRI; Irgasan, Sigma–Aldrich, San Luis, USA). Sterile distilled water was used to prepare biocide dilutions, except for TRI, where the solvent was 70% methanol (Panreac Química SAU, Barcelona, Spain). The MICs of biocides were determined by broth microdilution in 2 different media [Muller-Hinton Broth (MHB, Difco, Madrid, Spain) and minimum medium M9 (Sigma–Aldrich)], using serial 2-fold dilutions of each biocide as previously described.14 Biocide minimum inhibitory concentrations (MICs) were also determined at 2 incubation temperatures (25°C and 37°C) for 16–20h. K. pneumoniae subsp. pneumoniae (ATCC® 700603™) was used as control. All assays were performed in triplicate, expressing the MICs as the median of the 3 MIC values obtained for each biocide.

MICs within ±1log2 dilution step were considered identical. To verify that bacterial isolates are able to growth in any condition tested, 48h growth curves were performed under these four conditions (25°C and 37°C; MHB and M9 medium) using an Infinite 200 PRO spectrophotometer (Tecan Trading AG®, Switzerland).

Molecular typing and resistome

Whole genome sequencing (WGS) was performed using the MiSeq system (Illumina®, San Diego, CA, USA).15 Assignment of isolates to sequence type (ST) and characterisation of the resistome were determined using the nucleotide sequences of the genomes obtained by next-generation sequencing and the MLSTFinder 2.0 (https://cge.cbs.dtu.dk/services/MLST) and ResFinder 3.2 (https://cge.cbs.dtu.dk/services/ResFinder/), respectively. Clones that caused at least four recognised outbreaks and were reported in ≥10 countries were classified as HR clones. The emerging clone ST405 was also considered as HR.1

Detection of genes coding for efflux pumps

Gene annotation was performed with the RAST server (http://rast.nmpdr.org/). The genes coding for efflux pumps were searched from annotated genes or by manual search. The absence of genes not detected in some isolates by WGS (qacΔE and smvA) was confirmed by conventional PCR using specific primer pairs.

Statistics

Quantitative non-parametric variables were compared using the Mann-Whitney U test and Pearson's chi-squared, as appropriate, using IBM SPSS Statistics 18 (IBM Corporation, Armonk, NY). Differences of p<0.05 were considered statistically significant.

Results

As shown in Table 2, the median MICs (mg/L) of the biocides tested at 37°C in MHB were 1094 for SOD, whereas for the remaining biocides ranged between 1.9–0.5 (TRI), 19.5–1.2 (CHX), 15.6–7.8 (BEN), 35.6–4.5 (ETH), and 3125–1562 (POV). Using M9 medium (Table 3), the median MICs were 1 for SOD, whereas for the remaining biocide ranged between 0.08–0.04 (CHX), 0.2–0.1 (BEN), 0.28–0.07 (ETH), 1.9–0.1 (TRI), and 24.4–12.2 (POV).

Table 2.

Median MIC values (mg/L) of 6 biocides tested at 37°C and 25°C in MHB against 17 carbapenemase-producing K. pneumoniae isolates.

K. pneumoniae isolate  Median MIC (mg/L) determined in MHB
  Povidone-iodineSodium hypochloriteChlorhexidine digluconateBenzalkonium chlorideEthanolTriclosan
  37°C  25°C  37°C  25°C  37°C  25°C  37°C  25°C  37°C  25°C  37°C  25°C 
ST101/KPC-2  1562  1562  1094  1094  19.5  9.8  7.8  7.8  8.9  8.9  0.5  0.3 
ST258/KPC-3  3125  3125  1094  1094  4.9  4.9  7.8  7.8  8.9  8.9  1.9  0.5 
ST512/KPC-3  1562  3125  1094  1094  19.5  4.9  7.8  7.8  8.9  8.9  0.5  0.3 
ST11/VIM-1  1562  1562  1094  547  19.5  9.8  15.6  31.2  17.8  35.6  0.5  0.3 
ST15/VIM-1  1562  1562  1094  547  2.4  2.4  15.6  15.6  8.9  8.9  0.3  0.05 
ST147/VIM-1  3125  1562  1094  1094  4.9  4.9  15.6  15.6  17.8  17.8  1.9  1.9 
ST11/OXA-245  3125  1562  1094  547  9.8  4.9  7.8  7.8  8.9  17.8  0.5  0.5 
ST11/OXA-48  3125  1562  1094  1094  4.9  4.9  7.8  7.8  8.9  17.8  0.5  0.5 
ST15/OXA-48  3125  3125  1094  1094  1.2  4.9  7.8  7.8  8.9  17.8  0.5  0.5 
ST37/OXA-48  3125  3125  1094  1094  4.9  2.4  7.8  15.6  8.9  8.9  0.3  0.1 
ST405/OXA-48  1562  1562  1094  547  19.5  4.9  7.8  7.8  8.9  8.9  0.5  0.5 
ST340/VIM-1  3125  3125  1094  1094  19.5  4.9  7.8  15.6  8.9  8.9  0.9  0.5 
ST437/OXA-245  1562  1562  1094  547  9.8  2.4  7.8  7.8  8.9  17.8  0.9  0.9 
ST13/OXA-48  3125  1562  1094  1094  19.5  4.9  7.8  7.8  8.9  8.9  0.5  0.3 
ST16/OXA-48  3125  1562  1094  1094  19.5  4.9  7.8  7.8  8.9  17.8  0.5  0.5 
ST846/OXA-48  3125  1562  1094  1094  19.5  4.9  15.6  15.6  35.6  17.8  1.9  0.5 
ST899/OXA-48  3125  1562  1094  1094  9.8  9.8  7.8  7.8  4.5  4.5  0.1  0.1 
Table 3.

Median MIC values (mg/L) of 6 biocides tested at 37°C and 25°C in M9 medium against 17 carbapenemase-producing K. pneumoniae isolates.

K. pneumoniae isolate  Median MIC (mg/L) determined in M9 medium
  Povidone-iodineSodium hypochloriteChlorhexidine digluconateBenzalkonium chlorideEthanolTriclosan
  37°C  25°C  37°C  25°C  37°C  25°C  37°C  25°C  37°C  25°C  37°C  25°C 
ST101/KPC-2  12.2  12.2  0.08  0.04  0.1  0.1  0.14  0.14  0.3  0.1 
ST258/KPC-3  12.2  6.1  0.08  0.04  0.1  0.1  0.14  0.07  1.9  0.9 
ST512/KPC-3  12.2  12.2  0.08  0.04  0.1  0.1  0.14  0.07  0.9  0.5 
ST11/VIM-1  12.2  6.1  0.08  0.04  0.1  0.1  0.14  0.14  0.3  0.3 
ST15/VIM-1  12.2  6.1  0.5  0.08  0.04  0.1  0.1  0.14  0.14  0.1  0.3 
ST147/VIM-1  12.2  6.1  0.5  0.08  0.08  0.1  0.1  0.14  0.14  1.9  1.9 
ST11/OXA-245  12.2  6.1  0.08  0.04  0.2  0.1  0.14  0.14  0.5  0.5 
ST11/OXA-48  24.4  12.2  0.5  0.08  0.04  0.1  0.1  0.14  0.28  0.5  0.5 
ST15/OXA-48  12.2  6.1  0.5  0.04  0.04  0.1  0.1  0.07  0.07  0.5  0.3 
ST37/OXA-48  12.2  12.2  0.08  0.08  0.1  0.1  0.14  0.14  0.1  0.05 
ST405/OXA-48  24.4  12.2  0.08  0.04  0.2  0.1  0.28  0.28  0.1  0.1 
ST340/VIM-1  24.4  12.2  0.08  0.04  0.1  0.1  0.14  0.14  1.9  0.9 
ST437/OXA-245  12.2  12.2  0.5  0.08  0.04  0.1  0.1  0.14  0.07  1.9  0.9 
ST13/OXA-48  24.4  6.1  0.5  0.08  0.04  0.1  0.1  0.07  0.07  0.1  0.05 
ST16/OXA-48  12.2  12.2  0.5  0.08  0.08  0.1  0.1  0.14  0.14  0.5  0.5 
ST846/OXA-48  24.4  24.4  0.5  0.08  0.04  0.2  0.1  0.28  0.28  0.9  0.3 
ST899/OXA-48  24.4  12.2  0.08  0.04  0.1  0.1  0.14  0.14  0.1  0.05 

The median MICs at 25°C in MHB were the same as or slightly lower than those determined at 37°C (Table 2), and they ranged between 1.9–0.05 (TRI), 9.8–2.4 (CHX), 31.2–7.8 (BEN), 35.6–4.5 (ETH), 1094–547 (SOD), and 3125–1562 (POV). In contrast, using M9 medium (Table 3), the median MICs at 25°C were lower than those determined at 37°C. The median MICs of BEN was 0.1, whereas for the remaining biocides ranged between 0.08–0.04 (CHX), 1–0.5 (SOD), 1.9–0.05 (TRI), 0.28–0.07 (ETH), and 24.4–6.1 (POV).

The median MICs were higher at 37°C than 25°C, except for BEN, ETH and TRI, whose median MICs at 25°C were identical to those determined at 37°C. The median MIC values of the latter at both temperatures were: 7.8 in MHB (p=0.41) and 0.1 in M9 medium (p=0.07) for BEN; 8.9 in MHB (p=0.14) and 0.1 in M9 medium (p=0 .54) for ETH; and 0.5 in MHB (p=0.08) and 0.5 at 25°C and 0.2 at 37°C in M9 medium (p=0.23) for TRI. Considering dilution steps in MIC values instead of median MIC values, it was observed that MIC values were within ±2log2 dilution steps for CHX tested in MHB and within ±1log2 dilution steps for the remaining biocides (Tables 2 and 3).

With respect to the type of growth medium used (MHB or M9 medium), the differences observed in the MIC medians of the biocides were statistically significant for all of them (higher MIC medians in MHB than M9), except for TRI, whose MIC median was 0.5 in MHB and M9, both at 37°C (p = 0.47), and 0.5 in MHB and 0.2 in M9 medium at 25°C (p = 0.55). Considering dilution steps in MIC values instead of median MIC values, it was observed that MIC values were not within ±1log2 dilution step, except for TRI in most isolates (Tables 2 and 3).

No statistically significant differences were observed between the median MICs of biocides tested against isolates belonging to HR clones and those belonging to non-HR clones. With respect to the type of carbapenemase produced, no statistically significant differences were observed, except for VIM-1 producers which showed higher median MICs of BEN than OXA-48-producing isolates (37°C and 25°C; p=0.02 and p=0.01, respectively) or KPC-producing isolates (25°C, p=0.02).

The efflux pump genes cepA, acrAB, kpnEF and oqxAB were detected in all the isolates tested, whereas qacE and qacA were not detected at all (Table 4). smvAR was detected in all isolates, except for the one belonging to the OXA-48-producing ST15 clone (Table 4). Finally, the distribution of the efflux pump gene qacΔE was more variable (47% of isolates) (Table 4). No significant differences were observed between the presence or absence of smvAR and qacΔE and the median MICs of the biocides tested or the type of clone (HR or non-HR). Nevertheless, significant differences were observed between the presence of qacΔE and the presence of OXA-48-like (p=0.01) and VIM-1 carbapenemase (p=0.02).

Table 4.

Efflux pump genes detected in 17 carbapenemase-producing K. pneumoniae isolates.

K. pneumoniae isolate  Efflux pump genes
  cepA  acrAB  kpnEF  oqxAB  qacE  qacA  qacΔE  smvAR 
ST101/KPC-2  −  −  − 
ST258/KPC-3  −  − 
ST512/KPC-3  −  − 
ST11/VIM-1  −  − 
ST15/VIM-1  −  − 
ST147/VIM-1  −  − 
ST11/OXA-245  −  −  − 
ST11/OXA-48  −  − 
ST15/OXA-48  −  −  −  − 
ST37/OXA-48  −  −  − 
ST405/OXA-48  −  −  − 
ST340/VIM-1  −  − 
ST437/OXA-245  −  −  − 
ST13/OXA-48  −  −  − 
ST16/OXA-48  −  − 
ST846/OXA-48  −  −  − 
ST899/OXA-48  −  −  − 

+: detected; −: not detected.

Discussion

Since RSB may contribute to certain dissemination of CP-Kp clones, understanding how environmental conditions, such as temperature and the presence of organic material, could affect the biocidal activity and explore the mechanisms capable of reducing susceptibility in CP -Kp (e.g., efflux pumps) could be useful for the design of new infection prevention and control strategies. The present study evaluated (i) the effect of different growth temperatures (25°C and 37°C) and growth medium conditions (MHB and M9 medium) on the antimicrobial activity of 6 biocides tested against representative CP-Kp isolates belonging to HR or non-HR clones and (ii) the association between MICs of biocides and the presence of some efflux pumps able to extrude biocides.

Our results indicate that, based on the median MICs, the biocides with higher in vitro activity are TRI, CHX, BEN, and ETH, and this activity is much higher in M9 medium than MHB, except for TRI (similar in M9 and MHB). The impact of culture medium on MIC values has been described for various techniques such as microdilution and disk diffusion.16,17 The organic nutrients contained in MHB may inactivate or reduce the activity of these biocides, as was observed by Kawamura-Sato et al. in Acinetobacter baumannii.18 Our results suggest that the activity of the biocides analysed, with the exception of TRI, may be reduced in environments containing organic matter.

Regarding temperature effects on biocide in vitro activity, our results show that POV, CHX and SOD were more active (lower MIC medians) at 25°C than 37°C. This finding is partially in agreement with the results of other studies, such as the ones obtained by Lambert et al., who observed that the MIC of the biocides they tested were affected by the conditions under which the technique was performed, such as temperature.19 It is important to highlight that differences in biocide activity were only significant for CHX tested in MHB, considering the number of dilution steps of difference in MIC values instead of median MICs, so the impact of the temperature range we tested on biocide activity seems to be low. In any case, the higher in vitro activity of some biocides at 25°C may be related to higher chemical degradation of active compounds at 37°C than 25°C, or to better growth of Kp at 37°C than at 25°C.20 Regarding the results obtained for TRI, the absence of temperature effects would be in line with the results obtained by Kim et al., who observed that temperature increase (from 22 to 40°C) when using a soap with TRI does not significantly improve its antibacterial activity.21 Our results indicate that TRI is the biocide less affected by changes in growth medium or the temperatures we tested.

With respect to type of clone (HR or non-HR) or the type of carbapenemase produced, no statistically significant differences in median MICs were observed, suggesting that high-risk clones or the resistance determinants analysed are not related to susceptibility or tolerance to biocides. One exception to this was VIM-1 producers which showed higher median MICs of BEN tested on MHB than OXA-48-producing isolates (37°C and 25°C) or KPC-producing isolates (25°C). This could be explained by the possible co-mobilisation of the blaVIM-1 carbapenemase gene and biocide tolerance genes like qacΔE, both detected in class I integrons according to Pitout et al., and Guo et al., respectively.2,22 This association could not be established in our isolates because of the relatively reduced length of contigs containing blaVIM-1 and those containing qacΔE. The use of longer contigs generated by other genetic platforms (i.e.; PacBio) would be helpful in this context.

The presence of specific efflux pumps has been related to decreased susceptibility or tolerance to biocides.23 Our results indicate that the presence of genes encoding efflux pumps cepA, acrAB, kpnEF, and oqxAB does not appear to be related to the median MIC or biocide activity observed, or to the type of clone (HR or non-HR), since these genes were detected in all isolates analysed, which is in agreement with previous studies performed in CP-Kp and in non-CP-Kp.10,22,24–26

The prevalence of the cationic efflux pump SmvAR, described as an important cationic biocide efflux pump in Kp by Wand et al., is unknown in CP-Kp but is expected to be high, as we observed in our collection of isolates.7 In our study, the smvAR gene was detected in all isolates except in the one belonging to the OXA-48-producing ST15 clone, suggesting that the presence of this efflux pump gene is not related to type of clone.

The gene encoding the efflux pumps qacΔE was present in 47% of the isolates tested, and its presence or absence was not related to the activity of some of the biocides that are substrates of these pumps, type of carbapenemase produced or type of clone. The prevalence of the qacΔE gene in our study is similar to that previously described by Guo et al.22 The association between qacΔE and blaVIM-1 genes could be partially explained if both genetic determinants are carried out in the same plasmid.2,22

Finally, the qacE and qacA genes were not detected in our study. The absence of qacE is in agreement with the low prevalence (1/64) previously described by Abuzaid et al.9 The absence of qacA is in agreement to that previously described by Chen et al., but is in contrast to that previously described by Guo et al., who showed a prevalence of qacA gene of 41% or Vijayakumar et al., who describe a prevalence of 44.4%.22,27,28 This difference can probably be explained by differences in the methodology or in criteria used to select the isolates.

Regarding the effect of these genes on the values of biocide median MICs, our results are in consonance with those of Vijayakumar et al., who did not find significant differences between the in vitro activity of the biocides tested and the presence of cepA or qacE genes.28 On the other hand, these findings do not agree with the results of the study performed by Abuzaid et al., who observed a close association between RSB and the presence of cepA, qacΔE or qacE in Kp clinical isolates.9 This could be explained by the presence of additional efflux pumps other than QacA and QacΔE and/or by differences in the expression levels of these pumps in CP-Kp, as previously described by Yazgan et al.26

There is currently no proposed or recommended gold standard procedure or assay agreed between experts for biocide susceptibility testing. Multiple non-standardised methodologies are used for biocide susceptibility testing, such as minimum inhibitory concentration assay, quantitative suspension tests, qualitative suspension tests and carrier tests.29 This variability of methods makes it difficult to compare results from different studies and obtain clear conclusions. Biocide activity tested by mean of MIC determination can be controversial since in practice much higher biocide concentrations are used, and also because high MIC values are not always related with a decreased lethal effect as reported by Lear et al. but in spite of this methodological difficulty, many studies and reports on biocide tolerance and resistance are based on broth microdilution results.30 Nevertheless, MIC determination allowed us to evaluate the impact that different laboratory conditions (culture medium and temperature) could have on the method used to assess the biocidal activity and reflects the need for standardisation.

One limitation of our study is the relative limited number of clones of CP-Kp (e.g., absence of ST307) and type of carbapenemases (e.g., absence of NDM) included, however they represent the most prevalent clones in Spain at the time this work was designed. Another important limitation is the lack of information regarding the mRNA expression level of the efflux pump genes investigated. This could be relevant as the MICs of biocides may be related to the expression levels of some efflux pump genes.

In conclusion, our results suggest that the biocides with the highest activity against the CP-Kp isolates tested were CHX, BEN, ETH and TRI. Biocide activity is slightly affected by temperature (lower at 37°C than 25°C) whereas a great impact is observed regarding the type of growth medium (lower in MHB than in M9 medium), suggesting that organic matter can reduce the activity of most of the biocides studied. Moreover, biocide activity is not related to the clone type (HR vs no-HR), the ST or the type of carbapenemase produced neither to the presence or absence of the efflux pumps genes studied. The implementation of standardised and reproducible methods for in vitro biocide susceptibility testing are necessary for the application of effective disinfecting protocols, particularly in the context of nosocomial surveillance programs.

Funding

This study was funded by a grant (PI15-01172) from Instituto de Salud Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Economía Industria y Competitividad, the Spanish Network for Research in Infectious Diseases (RD16/0016/0001)-co-financed by European Development Regional Fund «A way to achieve Europe», Operative program Intelligent Growth 2014-2020.

Conflicts of interest

The authors declare that there are no conflicts of interest.

Acknowledgements

We thank the Reference Laboratory, Program for the Prevention and Control of Healthcare-Associated Infections and Antimicrobial Stewardship in Andalucía (PIRASOA, Servicio Andaluz de Salud), and the Study Group on Mechanisms of Action and Resistance to Antimicrobials, GEMARA (SEIMC, http://www.seimc.org/), for their collaboration.

References
[1]
S. Navon-Venezia, K. Kondratyeva, A. Carattoli.
Klebsiella pneumoniae: a major worldwide source and shuttle for antibiotic resistance.
FEMS Microbiol Rev, 41 (2017), pp. 252-275
[2]
J.D.D. Pitout, P. Nordmann, L. Poirel.
Carbapenemase-producing Klebsiella pneumoniae, a key pathogen set for global nosocomial dominance.
Antimicrob Agents Chemother, 59 (2015), pp. 5873-5884
[3]
S. Vergara-López, M.C. Domínguez, M.C. Conejo, Á. Pascual, J. Rodríguez-Baño.
Wastewater drainage system as an occult reservoir in a protracted clonal outbreak due to metallo-β-lactamase-producing Klebsiella oxytoca.
Clin Microbiol Infect, 19 (2013), pp. 490-498
[4]
A. Lerner, A. Adler, J. Abu-Hanna, I. Meitus, S. Navon-Venezia, Y. Carmeli.
Environmental contamination by carbapenem-resistant Enterobacteriaceae.
J Clin Microbiol, 51 (2013), pp. 177-181
[5]
J.Y. Maillard.
Resistance of bacteria to biocides.
Microbiol Spectr, 6 (2018), pp. 1-17
[6]
G. Kampf.
Biocidal agents used for disinfection can enhance antibiotic resistance in Gram-negative species.
Antibiotics, 7 (2018), pp. 110
[7]
M.E. Wand, L.J. Bock, L.C. Bonney, J.M. Sutton.
Mechanisms of increased resistance to chlorhexidine and cross-resistance to colistin following exposure of Klebsiella pneumoniae clinical isolates to chlorhexidine.
Antimicrob Agents Chemother, 61 (2017), pp. e01162-e1216
[8]
F. Fernández-Cuenca, M. Tomás, F.-J. Caballero-Moyano, G. Bou, L. Martínez-Martínez, J. Vila, et al.
Reduced susceptibility to biocides in Acinetobacter baumannii: association with resistance to antimicrobials, epidemiological behaviour, biological cost and effect on the expression of genes encoding porins and efflux pumps.
J Antimicrob Chemother, 70 (2015), pp. 3222-3229
[9]
A. Abuzaid, A. Hamouda, S.G.B. Amyes.
Klebsiella pneumoniae susceptibility to biocides and its association with cepA, qacΔE and qacE efflux pump genes and antibiotic resistance.
J Hosp Infect, 81 (2012), pp. 87-91
[10]
I. Türkel, T. Yıldırım, B. Yazgan, M. Bilgin, E. Başbulut.
Relationship between antibiotic resistance, efflux pumps, and biofilm formation in extended-spectrum β-lactamase producing Klebsiella pneumoniae.
J Chemother, 30 (2018), pp. 354-363
[11]
V.B. Srinivasan, G. Rajamohan.
KpnEF, a new member of the Klebsiella pneumoniae cell envelope stress response regulon, is an SMR-type efflux pump involved in broad-spectrum antimicrobial resistance.
Antimicrob Agents Chemother, 57 (2013), pp. 4449-4462
[12]
L.H. Hansen, L. Bogø Jensen, H.I. Sørensen, S.J. Sørensen.
Substrate specificity of the OqxAB multidrug resistance pump in Escherichia coli and selected enteric bacteria.
J Antimicrob Chemother, 60 (2007), pp. 145-147
[13]
J. Oteo, A. Ortega, R. Bartolomé, G. Bou, C. Conejo, M. Fernández-Martínez, et al.
Prospective multicenter study of carbapenemase-producing Enterobacteriaceae from 83 hospitals in Spain reveals high in vitro susceptibility to colistin and meropenem.
Antimicrob Agents Chemother, 59 (2015), pp. 3406-3412
[14]
Clinical and Laboratory Standards Institute (CLSI).
Performance standards for antimicrobial susceptibility testing: nineteenth informational supplement. Approved standard M100-S19, Wayne, PA.
(2009),
[15]
F. Fernández-Cuenca, P. Pérez-Palacios, F. Galán-Sánchez, L. López-Cerero, I. López-Hernández, R. López-Rojas, et al.
First identification of blaNDM-1 carbapenemase in blaOXA-94-producing Acinetobacter baumannii ST85 in Spain.
Enferm Infecc Microbiol Clin, 38 (2020), pp. 11-15
[16]
R.C. Tilton, L. Lieberman, E.H. Gerlach.
Microdilution antibiotic susceptibility test: examination of certain variables.
J Appl Microbiol, 26 (1973), pp. 658-665
[17]
V.C. Brenner, J.C. Sherris.
Influence of different media and bloods on results of diffusion antibiotic susceptibility tests.
Antimicrob Agents Chemother, 1 (1972), pp. 116-122
[18]
K. Kawamura-Sato, J-I. Wachino, T. Kondo, H. Ito, Y. Arakawa.
Reduction of disinfectant bactericidal activities in clinically isolated Acinetobacter species in the presence of organic material.
J Antimicrob Chemother, 61 (2008), pp. 568-576
[19]
R.J.W. Lambert, J. Pearson.
Susceptibility testing: accurate and reproducible minimum inhibitory concentration (MIC) and non-inhibitory concentration (NIC) values.
J Appl Microbiol, 88 (2000), pp. 784-790
[20]
J. Bengoechea, J. Pessoa, C. Whitfield.
Klebsiella pneumoniae infection biology: living to counteract host defences.
FEMS Microbiol Rev, 43 (2019), pp. 123-144
[21]
S.A. Kim, H. Moon, K. Lee, M.S. Rhee.
Bactericidal effects of triclosan in soap both in vitro and in vivo.
J Antimicrob Chemother, 70 (2015), pp. 3345-3352
[22]
W. Guo, K. Shan, B. Xu, J. Li.
Determining the resistance of carbapenem-resistant Klebsiella pneumoniae to common disinfectants and elucidating the underlying resistance mechanisms.
Pathog Glob Health, 109 (2015), pp. 184-192
[23]
L. Fernández, R.E.W. Hancock.
Adaptive and mutational resistance: role of porins and efflux pumps in drug resistance.
Clin Microbiol Rev, 25 (2012), pp. 661-681
[24]
A. Abuzaid, S.G.B. Amyes.
The genetic environment of the antiseptic resistance genes qacED and cepA in Klebsiella pneumoniae.
J Chemother, 27 (2015), pp. 139-145
[25]
R.L. Ferreira, B.C.M. Da Silva, G.S. Rezende, R. Nakamura-Silva, A. Pitondo-Silva, E.B. Campanini, et al.
High prevalence of multidrug-resistant Klebsiella pneumoniae harboring several virulence and β-lactamase encoding genes in a Brazilian intensive care unit.
Front Microbiol, 9 (2019), pp. 3198
[26]
B. Yazgan, I. Türkel, R. Güçkan, K. Kılınç, T. Yıldırım.
Comparison of biofilm formation and efflux pumps in ESBL and carbapenemase producing Klebsiella pneumoniae.
J Infect Dev Ctries, 12 (2018), pp. 156-163
[27]
Y. Chen, K. Liao, Y. Huang, P. Guo, H. Huang, Z. Wu, et al.
Determining the susceptibility of carbapenem resistant Klebsiella pneumoniae and Escherichia coli strains against common disinfectants at a tertiary hospital in China.
BMC Infect Dis, 20 (2020), pp. 88
[28]
R. Vijayakumar, T. Sandle, M.S. Al-Aboody, M.K. Alfonaisan, W. Alturaiki, S. Mickymaray.
Distribution of biocide resistant genes and biocides susceptibility in multidrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii—a first report from the Kingdom of Saudi Arabia.
J Infect Public Health, 11 (2018), pp. 812-816
[29]
A.T. Köhler, A.C. Rodloff, M. Labahn, M. Reinhardt, U. Truyen, S. Speck.
Evaluation of disinfectant efficacy against multidrug-resistant bacteria: a comprehensive analysis of different methods.
Am J Infect Control, 47 (2019), pp. 1181-1187
[30]
J.C. Lear, J.Y. Maillard, P.W. Dettmar, P.A. Goddard, A.D. Russell.
Chloroxylenol- and triclosan-tolerant bacteria from industrial sources.
J Ind Microbiol Biotechnol, 29 (2002), pp. 238-242

Data summary: The NCBI BioProject accession number is PRJNA631892.

These authors contributed equally.

Copyright © 2021. Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Quizás le interese:
10.1016/j.eimc.2024.07.015
No mostrar más